Schedule 13D ownership disclosure
Cyclacel Pharmaceuticals Inc
Security class unavailable · CUSIP: 23254L405
Event date: 2017-07-19
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,167,261
- Percent of class
- 29.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001408408-17-000019
- Form type
- SC 13D
- Filer
- Bio Green Med Solution, Inc.
- CIK
- CIK 1130166
- Filed
- Jul 27, 2017
- Reporting period
- Jul 19, 2017
- Description
- Schedule 13D beneficial ownership